Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Genomic Characterization and Classification of BCL6 Rearranged Follicular Lymphomas

Anu Amallraja, Gunes Gundem, Dylan Domenico, Juan E Arango Ossa, Umut Aypar, Jeeyeon Baik, Michael Kluk, Shenon Sethi, Katherine Lopez, David A. Qualls, Gilles Salles, Elli Papaemmanuil, Pallavi Galera, Ahmet Dogan

Blood (2024) 144 (Supplement 1): 1589.

https://doi.org/10.1182/blood-2024-203770

Published: 2024

Journal Articles

High Grade B-Cell Lymphoma with MYC/BCL6-Rearrangements (R) May Have Inferior Outcomes Compared to BCL2-R Disease

Blood (2024) 144 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2024-194144

Published: 2024

Journal Articles

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

Alex Tward, Roshal R. Patel, Irem Isgor, Pallavi Galera, Katherine Lopez, Beatrice Fregonese, Zachary Moore, Suzanne Wolden, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 3097.

https://doi.org/10.1182/blood-2024-210577

Published: 2024

Journal Articles

Precision Lineage Deconvolution in Mixed Phenotype Acute Leukemia Using Cite-Seq Derived Hematopoietic Stages Identifies Lineage Dynamics Associated with Treatment Response

Deepika Dilip, Pallavi Galera, David Nemirovsky, Morgan Lallo, Kamal Menghrajani, Andriy Derkach, Ross L Levine, Richard Koche, Wenbin Xiao, Jacob Glass

Blood (2023) 142 (Supplement 1): 4324.

https://doi.org/10.1182/blood-2023-188871

Published: 2023

Journal Articles

Real-Life Experience with Lenalidomide Plus Anti-CD20 Antibodies for the Treatment of Patients (pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Blood (2023) 142 (Supplement 1): 1686.

https://doi.org/10.1182/blood-2023-187783

Published: 2023

Journal Articles

Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience

Blood (2023) 142 (Supplement 1): 3129.

https://doi.org/10.1182/blood-2023-173562

Published: 2023

Journal Articles

Impact of Early Histological Transformation on Survival in Patients with Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 3023.

https://doi.org/10.1182/blood-2023-190325

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

Journal Articles

Clinical and Genomic Characterization of Secondary Acute Myeloid Leukemia with Mixed Phenotype

Pallavi Galera, Alexander Chan, Andriy Derkach, Ying Liu, Jeeyeon Baik, Christopher Famulare, Allison Sigler, Maria E. Arcila, Douglas A Mata, Ahmet Dogan, Martin S. Tallman, Ross L. Levine, Yanming Zhang, Mikhail Roshal, Jacob L Glass, Wenbin Xiao

Blood (2021) 138 (Supplement 1): 687.

https://doi.org/10.1182/blood-2021-151263

Published: 2021

Journal Articles

Deep Phenotyping Reveals Expansion of T Follicular Regulatory Cells and Triple Positive (CTLA4, TIGIT, PD1) Exhausted Effector Memory T Cells Characterizing the Immunosuppressive Microenvironment in Follicular Lymphoma

Sary El Daker, Daniel Freeman, Jeeyeon Baik, Menglei Zhu, Pratip Chattopadhyay, Mikhail Roshal, Ahmet Dogan, Pallavi Galera

Blood (2021) 138 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2021-153872

Published: 2021

Journal Articles

Distinct molecular profile of IRF4 -rearranged large B-cell lymphoma

Blood (2020) 135 (4): 274–286.

https://doi.org/10.1182/blood.2019002699

Published: 2020

Includes: Supplemental data

Journal Articles

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts

Blood (2018) 132 (Supplement 1): 1567.

https://doi.org/10.1182/blood-2018-99-114493

Published: 2018

Journal Articles

A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term Deep Remissions and Prolonged Progression-Free Duration Regardless of Age or Cytogenetic Risk after 5 Years of Follow up

Blood (2018) 132 (Supplement 1): 1957.

https://doi.org/10.1182/blood-2018-99-111712

Published: 2018

Journal Articles

Donor-derived MDS/AML in families with germline GATA2 mutation

Pallavi Galera, Amy P. Hsu, Weixin Wang, Stephenie Droll, Rui Chen, Jason R. Schwartz, Jeffery M. Klco, Sally Arai, Luke Maese, Christa Zerbe, Mark J. Parta, Neal S. Young, Steven M. Holland, Dennis D. Hickstein, Katherine R. Calvo

Blood (2018) 132 (18): 1994–1998.

https://doi.org/10.1182/blood-2018-07-861070

Published: 2018

Includes: Supplemental data

Journal Articles

The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL) Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets

Ravi Dashnamoorthy, PhD, Benjamin Chen, MD PhD, Pallavi Galera, Hong Chang, PhD, Afshin Beheshti, PhD, Srimoyee Ghosh, PhD, Andrew M Evens, DO,MSc

Blood (2017) 130 (Supplement 1): 2750.

https://doi.org/10.1182/blood.V130.Suppl_1.2750.2750

Published: 2017

NARROW

Genomic Characterization and Classification of BCL6 Rearranged Follicular Lymphomas

High Grade B-Cell Lymphoma with MYC/BCL6-Rearrangements (R) May Have Inferior Outcomes Compared to BCL2-R Disease

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

Precision Lineage Deconvolution in Mixed Phenotype Acute Leukemia Using Cite-Seq Derived Hematopoietic Stages Identifies Lineage Dynamics Associated with Treatment Response

Real-Life Experience with Lenalidomide Plus Anti-CD20 Antibodies for the Treatment of Patients (pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience

Impact of Early Histological Transformation on Survival in Patients with Follicular Lymphoma

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

Clinical and Genomic Characterization of Secondary Acute Myeloid Leukemia with Mixed Phenotype

Deep Phenotyping Reveals Expansion of T Follicular Regulatory Cells and Triple Positive (CTLA4, TIGIT, PD1) Exhausted Effector Memory T Cells Characterizing the Immunosuppressive Microenvironment in Follicular Lymphoma

Distinct molecular profile of IRF4 -rearranged large B-cell lymphoma

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts

A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term Deep Remissions and Prolonged Progression-Free Duration Regardless of Age or Cytogenetic Risk after 5 Years of Follow up

Donor-derived MDS/AML in families with germline GATA2 mutation

The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL) Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only